(CRGY) Crescent Energy - Overview
Stock: Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.10% |
| Yield on Cost 5y | 3.41% |
| Yield CAGR 5y | -8.67% |
| Payout Consistency | 92.2% |
| Payout Ratio | 87.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 53.7% |
| Relative Tail Risk | -2.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.32 |
| Alpha | -53.56 |
| Character TTM | |
|---|---|
| Beta | 1.732 |
| Beta Downside | 2.669 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.95% |
| CAGR/Max DD | -0.03 |
Description: CRGY Crescent Energy January 13, 2026
Crescent Energy Co (NYSE:CRGY) is a U.S.-based exploration and production firm that extracts crude oil, natural gas, and natural gas liquids primarily in Texas and the Rocky Mountain region. Founded in 2011 and headquartered in Houston, Texas, the company operates within the Oil & Gas Exploration & Production sub-industry.
As of 2023, Crescent reported average daily production of roughly 140,000 barrels of oil equivalent (boe/d), driven largely by its Permian Basin assets, and it completed the acquisition of SilverBow Resources in late 2022, expanding its footprint in the DJ Basin. The firm’s cash flow generation remains sensitive to WTI crude prices, which have averaged $78-$85 per barrel in 2023, and its debt-to-EBITDA ratio sits near 3.2×, indicating moderate leverage for a shale-focused E&P company.
For a deeper, data-driven look at CRGY’s valuation assumptions and scenario outcomes, you might explore the analytical tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 23.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -2.47 > 1.0 |
| NWC/Revenue: -4.50% < 20% (prev -2.40%; Δ -2.10% < -1%) |
| CFO/TA 0.17 > 3% & CFO 1.69b > Net Income 23.5m |
| Net Debt (3.22b) to EBITDA (1.47b): 2.19 < 3 |
| Current Ratio: 0.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (254.6m) vs 12m ago 19.78% < -2% |
| Gross Margin: 82.41% > 18% (prev 0.81%; Δ 8160 % > 0.5%) |
| Asset Turnover: 37.90% > 50% (prev 29.33%; Δ 8.57% > 0%) |
| Interest Coverage Ratio: 0.97 > 6 (EBITDA TTM 1.47b / Interest Expense TTM 290.4m) |
Altman Z'' 0.10
| A: -0.02 (Total Current Assets 702.7m - Total Current Liabilities 864.2m) / Total Assets 9.69b |
| B: 0.00 (Retained Earnings 15.7m / Total Assets 9.69b) |
| C: 0.03 (EBIT TTM 281.5m / Avg Total Assets 9.47b) |
| D: 0.00 (Book Value of Equity 15.7m / Total Liabilities 5.22b) |
| Altman-Z'' Score: 0.10 = B |
Beneish M -3.37
| DSRI: 0.78 (Receivables 524.6m/508.6m, Revenue 3.59b/2.71b) |
| GMI: 0.98 (GM 82.41% / 81.08%) |
| AQI: 0.67 (AQ_t 0.01 / AQ_t-1 0.02) |
| SGI: 1.32 (Revenue 3.59b / 2.71b) |
| TATA: -0.17 (NI 23.5m - CFO 1.69b) / TA 9.69b) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of CRGY shares?
Over the past week, the price has changed by +3.58%, over one month by +26.03%, over three months by +20.90% and over the past year by -27.25%.
Is CRGY a buy, sell or hold?
- StrongBuy: 9
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRGY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.4 | 32.2% |
| Analysts Target Price | 13.4 | 32.2% |
| ValueRay Target Price | 10.4 | 2.5% |
CRGY Fundamental Data Overview February 05, 2026
P/S = 0.8891
P/B = 0.714
Revenue TTM = 3.59b USD
EBIT TTM = 281.5m USD
EBITDA TTM = 1.47b USD
Long Term Debt = 3.22b USD (from longTermDebt, last quarter)
Short Term Debt = 3.64m USD (from shortTermDebt, last quarter)
Debt = 3.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 6.41b USD (3.19b + Debt 3.23b - CCE 3.53m)
Interest Coverage Ratio = 0.97 (Ebit TTM 281.5m / Interest Expense TTM 290.4m)
EV/FCF = -23.66x (Enterprise Value 6.41b / FCF TTM -271.1m)
FCF Yield = -4.23% (FCF TTM -271.1m / Enterprise Value 6.41b)
FCF Margin = -7.55% (FCF TTM -271.1m / Revenue TTM 3.59b)
Net Margin = 0.66% (Net Income TTM 23.5m / Revenue TTM 3.59b)
Gross Margin = 82.41% ((Revenue TTM 3.59b - Cost of Revenue TTM 631.6m) / Revenue TTM)
Gross Margin QoQ = 81.11% (prev 82.17%)
Tobins Q-Ratio = 0.66 (Enterprise Value 6.41b / Total Assets 9.69b)
Interest Expense / Debt = 2.25% (Interest Expense 72.6m / Debt 3.23b)
Taxrate = 21.0% (US default 21%)
NOPAT = 222.4m (EBIT 281.5m * (1 - 21.00%))
Current Ratio = 0.81 (Total Current Assets 702.7m / Total Current Liabilities 864.2m)
Debt / Equity = 0.72 (Debt 3.23b / totalStockholderEquity, last quarter 4.47b)
Debt / EBITDA = 2.19 (Net Debt 3.22b / EBITDA 1.47b)
Debt / FCF = -11.89 (negative FCF - burning cash) (Net Debt 3.22b / FCF TTM -271.1m)
Total Stockholder Equity = 3.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.25% (Net Income 23.5m / Total Assets 9.69b)
RoE = 0.61% (Net Income TTM 23.5m / Total Stockholder Equity 3.84b)
RoCE = 3.99% (EBIT 281.5m / Capital Employed (Equity 3.84b + L.T.Debt 3.22b))
RoIC = 3.11% (NOPAT 222.4m / Invested Capital 7.15b)
WACC = 7.01% (E(3.19b)/V(6.42b) * Re(12.30%) + D(3.23b)/V(6.42b) * Rd(2.25%) * (1-Tc(0.21)))
Discount Rate = 12.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 43.72%
Fair Price DCF = unknown (Cash Flow -271.1m)
EPS Correlation: -63.47 | EPS CAGR: -29.01% | SUE: -1.09 | # QB: 0
Revenue Correlation: 54.72 | Revenue CAGR: 18.18% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.34 | Chg30d=-0.038 | Revisions Net=-1 | Analysts=10
EPS next Year (2026-12-31): EPS=1.24 | Chg30d=-0.212 | Revisions Net=-4 | Growth EPS=-27.6% | Growth Revenue=+22.5%